These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 18469031)
1. Cerebrovascular dysplasia in neurofibromatosis type 1. Cairns AG; North KN J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1165-70. PubMed ID: 18469031 [TBL] [Abstract][Full Text] [Related]
2. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects. Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428 [TBL] [Abstract][Full Text] [Related]
3. MRI findings in children with neurofibromatosis type 1: a prospective study. Van Es S; North KN; McHugh K; De Silva M Pediatr Radiol; 1996 Jul; 26(7):478-87. PubMed ID: 8662066 [TBL] [Abstract][Full Text] [Related]
4. Occurrence of multiple Cerebral Cavernous Malformations in a patient with Neurofibromatosis type 1. Rerat K; Parker F; Nasser G; Vidaud D; Riant F; Tournier-Lasserve E; Denier C J Neurol Sci; 2015 Mar; 350(1-2):98-100. PubMed ID: 25702150 [TBL] [Abstract][Full Text] [Related]
5. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature. Friedrich RE; Nuding MA Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519 [TBL] [Abstract][Full Text] [Related]
6. Cerebrovascular stenosis in neurofibromatosis type 1 and utility of magnetic resonance angiography: our experience and literature review. D'Arco F; D'Amico A; Caranci F; Di Paolo N; Melis D; Brunetti A Radiol Med; 2014 Jun; 119(6):415-21. PubMed ID: 24297593 [TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis type 1 associated with vertebrobasilar dolichoectasia and pontine ischemic stroke. Giannantoni NM; Broccolini A; Frisullo G; Pilato F; Profice P; Morosetti R; Di Lella G; Zampino G; Della Marca G J Neuroimaging; 2015; 25(3):505-6. PubMed ID: 25230986 [TBL] [Abstract][Full Text] [Related]
8. Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study. Sabol Z; Resić B; Gjergja Juraski R; Sabol F; Kovac Sizgorić M; Orsolić K; Ozretić D; Sepić-Grahovac D Croat Med J; 2011 Aug; 52(4):488-96. PubMed ID: 21853543 [TBL] [Abstract][Full Text] [Related]
9. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough? Santoro C; Bernardo P; Coppola A; Pugliese U; Cirillo M; Giugliano T; Piluso G; Cinalli G; Striano S; Bravaccio C; Perrotta S Ital J Pediatr; 2018 Mar; 44(1):41. PubMed ID: 29566708 [TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas. Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074 [TBL] [Abstract][Full Text] [Related]
11. [Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1]. Blanchard G; Pinson S; Rousselle C; Lorthois S; Combemale P; Bernard M; Lion Francois L Arch Pediatr; 2009 Dec; 16(12):1527-32. PubMed ID: 19864117 [TBL] [Abstract][Full Text] [Related]
12. Spinal Cord Hyperintensities in Neurofibromatosis Type 1: Are They the Cord Equivalent of Unidentified Bright Objects in the Brain? Rüegger AD; Coleman L; Hansford JR; McLean N; Dabscheck G Pediatr Neurol; 2018 Sep; 86():63-65. PubMed ID: 30174245 [TBL] [Abstract][Full Text] [Related]
13. 1H MR spectroscopy evidence for the varied nature of asymptomatic focal brain lesions in neurofibromatosis type 1. Jones AP; Gunawardena WJ; Coutinho CM Neuroradiology; 2001 Jan; 43(1):62-7. PubMed ID: 11214651 [TBL] [Abstract][Full Text] [Related]
14. Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1. Wimmer K; Rosenbaum T; Messiaen L Clin Genet; 2017 Apr; 91(4):507-519. PubMed ID: 27779754 [TBL] [Abstract][Full Text] [Related]
15. Nevus Anemicus As an Additional Diagnostic Marker of Neurofibromatosis Type 1 in Childhood. Vaassen P; Rosenbaum T Neuropediatrics; 2016 Jun; 47(3):190-3. PubMed ID: 27019377 [TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis type 1 associated with moyamoya syndrome in children. Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170 [TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Rosser TL; Vezina G; Packer RJ Neurology; 2005 Feb; 64(3):553-5. PubMed ID: 15699396 [TBL] [Abstract][Full Text] [Related]
18. [Neurofibromatosis in children. Our experience]. López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048 [TBL] [Abstract][Full Text] [Related]
19. [Neurofibromatosis type 1 in children. Experiences of the Gdansk Paediatric Oncohaematology Centre. Preliminary results]. Sierota D; Stefanowicz J; Wierzba J; Adamkiewicz-Drozyńska E; Wybieralska-Dubaniewicz M; Kosiak W; Komasara L; Czauderna P; Izycka-Swieszewska E; Pilarska E; Birkholtz D; Stachowicz-Stencel T; Połczyńska K; Bień E; Szołkiewicz A; Stefanowicz A; Balcerska A Med Wieku Rozwoj; 2007; 11(3 Pt 2):307-12. PubMed ID: 18663272 [TBL] [Abstract][Full Text] [Related]
20. Disappearing enhancing brain lesion in a child with neurofibromatosis type I. Morris PW; Glasier CM; Smirniotopoulos JG; Allison JW Pediatr Radiol; 1997 Mar; 27(3):260-1. PubMed ID: 9126587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]